AUS
NZ
UK
CA
USA
IND
Highlights
Haleon plc disclosed ordinary share acquisitions by two senior executives on the London Stock Exchange.
Shares were purchased under the company’s Share Reward Plan with matching shares granted.
Transactions reported in compliance with UK Market Abuse Regulation.
Haleon plc, a consumer healthcare company listed on the FTSE, has reported the acquisition of ordinary shares by two members of its executive leadership. The transactions were conducted on the London Stock Exchange in accordance with regulatory disclosure requirements.
Details of the Share Acquisitions
The company confirmed that Adrian Morris, General Counsel, and Tamara Rogers, Chief Marketing Officer, each took part in its Share Reward Plan. Both executives purchased an allocation of shares at a fixed price and were granted an equal number of matching shares at no cost. The plan operates to align the interests of senior leadership with those of shareholders by providing an opportunity to acquire equity in the company through a structured mechanism.
Share Reward Plan Structure
Under this plan, participants can purchase a set number of shares, with the company awarding a corresponding number of additional shares without any purchase requirement. The scheme is part of Haleon’s broader remuneration framework designed to support employee engagement and long-term alignment with corporate objectives. While available to employees in various roles, the disclosure requirements apply specifically to individuals who hold managerial responsibilities under UK regulations.
Regulatory Compliance
The disclosure of these transactions adheres to the UK Market Abuse Regulation, which requires timely reporting of dealings in the company’s shares by persons in positions of managerial responsibility. Such reporting ensures transparency in the financial markets and provides stakeholders with insight into the participation of senior leaders in company equity plans. The notification to the exchange was made as part of this compliance process, detailing the identities of the executives, the nature of the transactions, and the number of shares involved.
Haleon’s Market Presence
Haleon plc is recognised as a leading player in the consumer healthcare sector, with operations spanning multiple regions and a diverse portfolio of well-known brands. The company maintains dual listings on both the London Stock Exchange under the ticker LSE:HLN and on the New York Stock Exchange. The acquisition of shares by senior executives adds to publicly available records of equity transactions, reflecting ongoing participation in structured share-based programmes.
Administrative Details
The transactions were executed on the London Stock Exchange and recorded in the company’s public filings. Each executive’s acquisition comprised a purchased portion and a matched portion under the same transaction date. Such arrangements are a routine element of employee share schemes across many listed companies, and disclosures are made in line with established corporate governance standards.
Frequently Asked Questions
- Which executives were involved in Haleon’s reported share acquisition?
Adrian Morris and Tamara Rogers participated in the acquisition. - On which exchange were the transactions conducted?
The transactions took place on the London Stock Exchange. - What regulatory framework governs such disclosures?
The UK Market Abuse Regulation requires these reports.
